<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Tigecycline</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Tigecycline">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Tigecycline</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Tigecycline</b> is an antibiotic for a number of bacterial infections.<span class="mw-ref" id="cite_ref-Rose-Rybak_2-0"><a href="#cite_note-Rose-Rybak-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-Kasbekar_3-0"><a href="#cite_note-Kasbekar-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> It is a glycylcycline administered intravenously. It was developed in response to the growing rate of antibiotic resistant  bacteria such as <i>Staphylococcus aureus</i>, <i>Acinetobacter baumannii</i>, and <i>E. coli</i>.<span class="mw-ref" id="cite_ref-Rose-Rybak_2-1"><a href="#cite_note-Rose-Rybak-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> As a tetracycline derivative antibiotic, its structural modifications has expanded its therapeutic activity to include Gram-positive and Gram-negative organisms, including those of multi-drug resistance.</p>

<p></p>
<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Tigecycline</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Tigecycline.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Tigecycline.svg.png" data-file-width="512" data-file-height="179" data-file-type="drawing" height="105" width="300"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pronunciation</th><td><span class="rt-commentedText nowrap"><span class="IPA nopopups noexcerpt">/<span style="border-bottom:1px dotted"><span>ˌ</span><span>t</span><span>aɪ</span><span>ɡ</span><span>ə</span><span>ˈ</span><span>s</span><span>aɪ</span><span>k</span><span>l</span><span>iː</span><span>n</span></span>/</span></span><span> </span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Tygacil</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/monograph/tigecycline.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/tigecycline.html'" tppabs="https://www.drugs.com/monograph/tigecycline.html" class="external text external">Monograph</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">License data</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">EU</abbr></small><span>&nbsp;</span>EMA:<span>&nbsp;</span><span><a href="javascript:if(confirm('http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Tigecycline  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Tigecycline'" tppabs="http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Tigecycline" class="external text external">by INN</a></span></li></ul></div>
</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>D<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>D (Evidence of risk)<span> </span></li></ul>

<ul></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>IV only</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>J01AA12<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=J01AA12  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=J01AA12'" tppabs="https://www.whocc.no/atc_ddd_index/?code=J01AA12" class="external text external">WHO</a></span>)<span> </span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>S4 (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>℞-only<span> </span></li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Protein binding</th><td>71–89%</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>Not metabolized</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>42.4 hours</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>59% biliary, 33% renal</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;"><i>N</i>-[(5a<i>R</i>,6a<i>S</i>,7<i>S</i>,9<i>Z</i>,10a<i>S</i>)-9-(amino-hydroxy-methylidene)-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5a,6,6a,7-tetrahydro-5<i>H</i>-tetracen-2-yl]-2-(tert-butylamino) acetamide<span class="mw-ref" id="cite_ref-1"><a href="#cite_note-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=220620-09-7  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=220620-09-7'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=220620-09-7" class="external text external">220620-09-7</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/5282044  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/5282044'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/5282044" class="external text external">5282044</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB00560  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB00560'" tppabs="https://www.drugbank.ca/drugs/DB00560" class="external text external">DB00560</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.10482314.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.10482314.html'" tppabs="http://www.chemspider.com/Chemical-Structure.10482314.html" class="external text external">10482314</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=70JE2N95KR  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=70JE2N95KR'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=70JE2N95KR" class="external text external">70JE2N95KR</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D01079  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D01079'" tppabs="https://www.kegg.jp/entry/D01079" class="external text external">D01079</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEBI</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:149836  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:149836'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:149836" class="external text external">CHEBI:149836</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL376140  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL376140'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL376140" class="external text external">ChEMBL376140</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID2048581  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID2048581'" tppabs="https://comptox.epa.gov/dashboard/DTXSID2048581" class="external text external">DTXSID2048581</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.211.439  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.211.439'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.211.439" class="external text external">100.211.439</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>29</sub><span>H</span><sub>39</sub><span>N</span><sub>5</sub><span>O</span><sub>8</sub></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">585.658</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=CC%28C%29%28C%29NCC%28%3DO%29Nc1cc%28c2C%5BC%40H%5D3C%5BC%40H%5D4%5BC%40H%5D%28N%28C%29C%29C%28%5CO%29%3DC%28%5CC%28N%29%3DO%29C%28%3DO%29%5BC%40%40%5D4%28O%29C%28%2FO%29%3DC3%2FC%28%3DO%29c2c1O%29N%28C%29C  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=CC%28C%29%28C%29NCC%28%3DO%29Nc1cc%28c2C%5BC%40H%5D3C%5BC%40H%5D4%5BC%40H%5D%28N%28C%29C%29C%28%5CO%29%3DC%28%5CC%28N%29%3DO%29C%28%3DO%29%5BC%40%40%5D4%28O%29C%28%2FO%29%3DC3%2FC%28%3DO%29c2c1O%29N%28C%29C'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=CC%28C%29%28C%29NCC%28%3DO%29Nc1cc%28c2C%5BC%40H%5D3C%5BC%40H%5D4%5BC%40H%5D%28N%28C%29C%29C%28%5CO%29%3DC%28%5CC%28N%29%3DO%29C%28%3DO%29%5BC%40%40%5D4%28O%29C%28%2FO%29%3DC3%2FC%28%3DO%29c2c1O%29N%28C%29C" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">CC(C)(C)NCC(=O)Nc1cc(c2C[C@H]3C[C@H]4[C@H](N(C)C)C(\O)=C(\C(N)=O)C(=O)[C@@]4(O)C(/O)=C3/C(=O)c2c1O)N(C)C</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C29H39N5O8/c1-28(2,3)31-11-17(35)32-15-10-16(33(4)5)13-8-12-9-14-21(34(6)7)24(38)20(27(30)41)26(40)29(14,42)25(39)18(12)23(37)19(13)22(15)36/h10,12,14,21,31,36,38-39,42H,8-9,11H2,1-7H3,(H2,30,41)(H,32,35)/t12-,14-,21-,29-/m0/s1<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:FPZLLRFZJZRHSY-HJYUBDRYSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=460956607&page2=Tigecycline  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=460956607&page2=Tigecycline'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=460956607&page2=Tigecycline" class="external text external">(verify)</a></span></span></td></tr></tbody></table>

<p>Tigecycline is marketed by Pfizer under the brand name <b>Tygacil.</b> It was given a U.S. Food and Drug Administration (FDA) fast-track approval and was approved on 17 June 2005.<span class="mw-ref" id="cite_ref-Rose-Rybak_2-2"><a href="#cite_note-Rose-Rybak-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-Kasbekar_3-1"><a href="#cite_note-Kasbekar-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>

<p>It was removed from the World Health Organization's List of Essential Medicines in 2019.<span class="mw-ref" id="cite_ref-WHO21st_4-0"><a href="#cite_note-WHO21st-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-5"><a href="#cite_note-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span></p>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_uses">Medical uses</h2></summary>
    
<p>Tigecycline is used to treat different kinds of bacterial infections, including complicated skin and structure infections, complicated intra-abdominal infections and community-acquired bacterial pneumonia. Tigecycline is a glycylcycline antibiotic that covers MRSA and Gram-negative organisms:</p>

<ul><li>Tigecycline can treat complicated skin and structure infections caused by; <i>Escherichia coli</i>, vancomycin-susceptible <i>Enterococcus faecalis</i>, methicillin-resistant <i>Staphylococcus aureus</i> (MRSA), <i>Streptococcus agalactiae</i>, <i>Streptococcus anginosus</i> grp., <i>Streptococcus pyogenes</i>, <i>Enterobacter cloacae</i>, <i>Klebsiella pneumoniae</i>, and <i>Bacteroides fragilis</i>.<span class="mw-ref" id="cite_ref-Labeling_6-0"><a href="#cite_note-Labeling-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></li>
<li>Tigecycline is indicated for treatment of complicated intra-abdominal infections caused by; <i>Citrobacter freundii</i>, <i>Enterobacter cloacae</i>, <i>Escherichia coli</i>, <i>Klebsiella oxytoca</i>, <i>Klebsiella pneumoniae</i>, vancomycin-susceptible <i>Enterococcus faecalis</i>, methicillin-resistant <i>Staphylococcus aureus</i> (MRSA), <i>Streptococcus anginosus</i> grp., <i>Bacteroides fragilis</i>, <i>Bacteroides thetaiotaomicron</i>, <i>Bacteroides uniformis</i>, <i>Bacteroides vulgatus</i>, <i>Clostridium perfringens</i>, and <i>Peptostreptococcus micros</i>.<span class="mw-ref" id="cite_ref-Labeling_6-1"><a href="#cite_note-Labeling-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></li>
<li>Tigecycline may be used for treatment of community-acquired bacterial pneumonia caused by; penicillin susceptible <i>Streptococcus pneumoniae</i>, <i>Haemophilus influenzae</i> that does not produce Beta-lactamase and <i>Legionella pneumophila</i>.<span class="mw-ref" id="cite_ref-Labeling_6-2"><a href="#cite_note-Labeling-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></li></ul>
   
<p>Tigecycline is given intravenously and has activity against a variety of Gram-positive and Gram-negative bacterial pathogens, many of which are resistant to existing antibiotics. Tigecycline successfully completed phase III trials in which it was at least equal to intravenous <a href="Vancomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Vancomycin" title="Vancomycin">vancomycin</a> and <a href="Aztreonam.htm" tppabs="https://ptable.com/wiki/compounds/A/Aztreonam" title="Aztreonam">aztreonam</a> to treat complicated skin and skin structure infections, and to intravenous <a href="Imipenem.htm" tppabs="https://ptable.com/wiki/compounds/A/Imipenem" title="Imipenem">imipenem</a> and cilastatian to treat complicated intra-abdominal infections.<span class="mw-ref" id="cite_ref-7"><a href="#cite_note-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> Tigecycline is active against many Gram-positive bacteria, Gram-negative bacteria and anaerobes – including activity against methicillin-resistant <i>Staphylococcus aureus</i> (MRSA),  <i>Stenotrophomonas maltophilia</i>, <i>Haemophilus influenzae</i>, and <i>Neisseria gonorrhoeae</i> (with MIC values reported at 2<span>&nbsp;</span>µg/mL) and multi-drug resistant strains of <i>Acinetobacter baumannii</i>. It has no activity against <i>Pseudomonas</i> spp. or <i>Proteus</i> spp.  The drug is licensed for the treatment of skin and soft tissue infections as well as intra-abdominal infections.</p>

<p>The European Society of Clinical Microbiology and Infection recommends tigecycline as a potential salvage therapy for severe and/or complicated or refractory <i>Clostridium difficile</i> infection.<span class="mw-ref" id="cite_ref-Kaewpoowat_8-0"><a href="#cite_note-Kaewpoowat-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span></p>

<p>Tigecycline can also be used in vulnerable populations such as immunocompromised patients or patients with cancer.<span class="mw-ref" id="cite_ref-Kaewpoowat_8-1"><a href="#cite_note-Kaewpoowat-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> Tigecycline may also have potential for use in acute myeloid leukemia.<span class="mw-ref" id="cite_ref-Skrtić20112_9-0"><a href="#cite_note-Skrtić20112-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Susceptibility_data">Susceptibility data</h3></summary>
    
<p>Tigecycline targets both Gram-positive and Gram-negative bacteria including a few key multi-drug resistant pathogens. The following represents MIC susceptibility data for a few medically significant bacterial pathogens.</p>
<ul><li><i>Escherichia coli</i>: 0.015 <i>μ</i>g/mL — 4 <i>μ</i>g/mL</li>
<li><i>Klebsiella pneumoniae</i>: 0.06 <i>μ</i>g/mL — 16 <i>μ</i>g/mL</li>
<li><i>Staphylococcus aureus</i> (methicillin-resistant): 0.03 <i>μ</i>g/mL — 2 <i>μ</i>g/mL<span class="mw-ref" id="cite_ref-10"><a href="#cite_note-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></li></ul>

<p>Tigecycline generally has poor activity against most strains of <i>Pseudomonas</i>.<span class="mw-ref" id="cite_ref-11"><a href="#cite_note-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Dosing">Dosing</h3></summary>
    
<p>Tigecycline is given by slow intravenous infusion (30 to 60 minutes) every 12 hours. People with impaired liver function need to be given a lower dose. No adjustment is needed for patients with impaired kidney function. It is not licensed for use in children. There is no oral form available.<span class="mw-ref" id="cite_ref-Labeling_6-3"><a href="#cite_note-Labeling-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Liver_or_kidney_problems">Liver or kidney problems</h3></summary>
    
<p>Tigecycline does not require dose adjustment for people with mild to moderate liver problems. However, in people with severe liver problems dosing should be decreased and closely monitored.<span class="mw-ref" id="cite_ref-Labeling_6-4"><a href="#cite_note-Labeling-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></p>

<p>Tigecycline does not require dose changes in people with poor kidney function or having hemodialysis.<span class="mw-ref" id="cite_ref-Labeling_6-5"><a href="#cite_note-Labeling-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Resistance_mechanisms">Resistance mechanisms</h3></summary>
    
<p>Bacterial resistance towards tigecycline in Enterobacteriaceae (such as <i>E. coli)</i> is often caused by genetic mutations leading to an up-regulation of bacterial efflux pumps, such as the RND type efflux pump AcrAB. Some bacterial species such as <i>Pseudomonas</i> spp. can be naturally resistant to tigecycline through the constant over-expression of such efflux pumps. In some Enterobacteriaceae species, mutations in ribosomal genes such as <i>rpsJ</i><span>&nbsp;</span>have been found to cause resistance to tigecycline.<span class="mw-ref" id="cite_ref-12"><a href="#cite_note-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Side_effects">Side effects</h2></summary>
    
<p>As a tetracycline derivative, tigecycline exhibits similar <a href="Tetracycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetracycline" title="Tetracycline">side effects</a> to the class of antibiotics. Gastrointestinal (GI) symptoms are the most common reported side effect.<span class="mw-ref" id="cite_ref-Kaewpoowat_8-2"><a href="#cite_note-Kaewpoowat-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span></p>

<p>Common side effects of tigecycline include nausea and vomiting.<span class="mw-ref" id="cite_ref-13"><a href="#cite_note-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> Nausea (26%) and vomiting (18%) tend to be mild or moderate and usually occur during the first two days of therapy.<span class="mw-ref" id="cite_ref-FDA_14-0"><a href="#cite_note-FDA-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span></p>

<p>Rare adverse effects (&lt;2%) include: swelling, pain, and irritation at injection site, anorexia, jaundice, hepatic dysfunction, pruritus, acute pancreatitis, and increased prothrombin time.<span class="mw-ref" id="cite_ref-FDA_14-1"><a href="#cite_note-FDA-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Precautions">Precautions</h3></summary>
    
<p>Precaution is needed when taken in individuals with tetracycline hypersensitivity, pregnant women, and children. It has been found to cause fetal harm when administered during pregnancy and therefore is classified as pregnancy category D.<span class="mw-ref" id="cite_ref-Labeling_6-6"><a href="#cite_note-Labeling-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> In rats or rabbits, tigecycline crossed the placenta and was found in the fetal tissues, and is associated with slightly lower birth weights as well as slower bone ossification. Even though it was not considered teratogenic, tigecycline should be avoided unless benefits outweigh the risks.<span class="mw-ref" id="cite_ref-FDA_14-2"><a href="#cite_note-FDA-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> In addition, its use during childhood can cause yellow-grey-brown discoloration of the teeth and should not be used unless necessary.</p>

<p>More so, there are clinical reports of tigecycline-induced acute pancreatitis, with particular relevance to patients also diagnosed with cystic fibrosis.<span class="mw-ref" id="cite_ref-pmid26282838_15-0"><a href="#cite_note-pmid26282838-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></p>

<p>Tigecycline showed an <i>increased</i> mortality in patients treated for hospital-acquired pneumonia, especially ventilator-associated pneumonia (a non-approved use), but also in patients with complicated skin and skin structure infections, complicated intra-abdominal infections and diabetic foot infection.<span class="mw-ref" id="cite_ref-FDA_14-3"><a href="#cite_note-FDA-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> Increased mortality was in comparison to other treatment of the same types of infections. The difference was not statistically significant for any type, but mortality was numerically greater for every infection type with Tigecycline treatment, and prompted a black box warning by the FDA.<span class="mw-ref" id="cite_ref-16"><a href="#cite_note-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Black_box_warning">Black box warning</h3></summary>
    
<p>FDA issued a black box warning in September 2010, for tigecycline regarding an increased risk of death compared to other appropriate treatment.<span class="mw-ref" id="cite_ref-FDA_14-4"><a href="#cite_note-FDA-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span><span class="mw-ref" id="cite_ref-Dixit_17-0"><a href="#cite_note-Dixit-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> As a result of increase in total death rate (cause is unknown) in individuals taking this drug, tigecycline is reserved for situations in which alternative treatment is not suitable.<span class="mw-ref" id="cite_ref-Labeling_6-7"><a href="#cite_note-Labeling-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-Dixit_17-1"><a href="#cite_note-Dixit-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span></p>

<p>In 2010, the U.S. Food and Drug Administration (FDA) updated the warnings section of the drug label to include information regarding increased mortality risk (seen most clearly in people treated for hospital-acquired pneumonia, especially ventilator-associated pneumonia).</p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Drug_interactions">Drug interactions</h3></summary>
    
<p>Tigecycline has been found to interact with medications, such as:</p>
<ul><li><a href="Warfarin.htm" tppabs="https://ptable.com/wiki/compounds/A/Warfarin" title="Warfarin">Warfarin</a>: Since both tigecycline and warfarin bind to serum or plasma proteins, there is potential for protein-binding interactions, such that one drug will have more effect than the other. Although dose adjustment is not necessary, INR and prothrombin time should be monitored if given concurrently.<span class="mw-ref" id="cite_ref-18"><a href="#cite_note-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span></li>
<li>Oral contraceptives: Effectiveness of oral contraceptives are decreased with concurrent use due to reduction in the concentration levels of oral contraceptives.</li></ul>
<p>However, the mechanism behind these drug interactions have not been fully analyzed.<span class="mw-ref" id="cite_ref-FDA_14-5"><a href="#cite_note-FDA-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Mechanism_of_action">Mechanism of action</h2></summary>
    
<p>Tigecycline is broad-spectrum antibiotic that acts as a protein synthesis inhibitor. It exhibits bacteriostatic activity by binding to the 30S ribosomal subunit of bacteria and thereby blocking the interaction of aminoacyl-tRNA with the A site of the ribosome.<span class="mw-ref" id="cite_ref-19"><a href="#cite_note-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span> In addition, tigecycline has demonstrated bactericidal activity against isolates of <i>S. pneumoniae</i> and <i>L. pneumophila.</i><span class="mw-ref" id="cite_ref-FDA_14-6"><a href="#cite_note-FDA-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span></p>

<p>It is a third generation tetracycline derivative within a class called glycylcyclines which carry a <i>N</i>,<i>N</i>-dimethyglycylamido (DMG) moiety attached to the 9-position of tetracycline ring D.<span class="mw-ref" id="cite_ref-Nguyen_20-0"><a href="#cite_note-Nguyen-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span> With structural modifications as a 9-DMG derivative of <a href="Minocycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Minocycline" title="Minocycline">minocycline</a>, tigecycline has been found to improve minimal inhibitory concentrations against Gram-negative and Gram-positive organisms, when compared to tetracyclines.<span class="mw-ref" id="cite_ref-Nguyen_20-1"><a href="#cite_note-Nguyen-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacokinetics">Pharmacokinetics</h2></summary>
    
<p>Tigecycline is metabolized through glucuronidation into glucuronide conjugates and <i>N</i>-acetyl-9-aminominocycline metabolite.<span class="mw-ref" id="cite_ref-Hoffman_21-0"><a href="#cite_note-Hoffman-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span> Therefore, dose adjustments are needed for patients with severe hepatic impairment.<span class="mw-ref" id="cite_ref-FDA_14-7"><a href="#cite_note-FDA-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> More so, it is primarily eliminated unchanged in the feces and secondarily eliminated by the kidneys.<span class="mw-ref" id="cite_ref-Hoffman_21-1"><a href="#cite_note-Hoffman-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span> No renal adjustments are necessary.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Society_and_culture">Society and culture</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Approval">Approval</h3></summary>
    
<p>It is approved to treat complicated skin and soft tissue infections (cSSTI), complicated intra-abdominal infections (cIAI), and community-acquired bacterial pneumonia (CAP) in individuals 18 years and older.<span class="mw-ref" id="cite_ref-Rose-Rybak_2-3"><a href="#cite_note-Rose-Rybak-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-Kasbekar_3-2"><a href="#cite_note-Kasbekar-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-Hoffman_21-2"><a href="#cite_note-Hoffman-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span><span class="mw-ref" id="cite_ref-FDA_14-8"><a href="#cite_note-FDA-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span>
In the United Kingdom it is approved in adults and in children from the age of eight years for the treatment of complicated skin and soft tissue infections (excluding diabetic foot infections) and complicated intra-abdominal infections in situations where other alternative antibiotics are not suitable.<span class="mw-ref" id="cite_ref-22"><a href="#cite_note-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Other_names">Other names</h3></summary>
    
<ul><li>GAR-936<span class="mw-ref" id="cite_ref-23"><a href="#cite_note-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span></li>
<li>Tygacil</li>
<li>Tigeplug (marketed by Biocon, India)</li>
<li>Tigilyn (Marketed by Real Value therapy pharmaceuticals company in Myanmar, Manufactured by Lyka)</li></ul>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-1"> <span id="mw-reference-text-cite_note-1" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://data.epo.org/publication-server/rest/v1.0/publication-dates/20160831/patents/EP2181330NWB2/document.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://data.epo.org/publication-server/rest/v1.0/publication-dates/20160831/patents/EP2181330NWB2/document.html'" tppabs="https://data.epo.org/publication-server/rest/v1.0/publication-dates/20160831/patents/EP2181330NWB2/document.html" class="external text external">"EP2181330"</a>. <i>European Patent Office</i><span class="reference-accessdate">. Retrieved <span class="nowrap">29 September</span> 2017</span>.</cite></span></li><li id="cite_note-Rose-Rybak-2"> <span id="mw-reference-text-cite_note-Rose-Rybak-2" class="mw-reference-text"><cite id="CITEREFRoseRybak2006" class="citation journal cs1">Rose W, Rybak M (2006). "Tigecycline: first of a new class of antimicrobial agents". <i>Pharmacotherapy</i>. <b>26</b> (8): 1099–110. doi:<a href="javascript:if(confirm('https://doi.org/10.1592%2Fphco.26.8.1099  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1592%2Fphco.26.8.1099'" tppabs="https://doi.org/10.1592%2Fphco.26.8.1099" class="external text external">10.1592/phco.26.8.1099</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16863487  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16863487'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16863487" class="external text external">16863487</a>.</cite></span></li><li id="cite_note-Kasbekar-3"> <span id="mw-reference-text-cite_note-Kasbekar-3" class="mw-reference-text"><cite id="CITEREFKasbekar_N2006" class="citation journal cs1">Kasbekar N (2006). "Tigecycline: a new glycylcycline antimicrobial agent". <i>Am J Health Syst Pharm</i>. <b>63</b> (13): 1235–43. doi:<a href="javascript:if(confirm('https://doi.org/10.2146%2Fajhp050487  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2146%2Fajhp050487'" tppabs="https://doi.org/10.2146%2Fajhp050487" class="external text external">10.2146/ajhp050487</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16790575  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16790575'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16790575" class="external text external">16790575</a>.</cite></span></li><li id="cite_note-WHO21st-4"> <span id="mw-reference-text-cite_note-WHO21st-4" class="mw-reference-text"><cite id="CITEREFWorld_Health_Organization2019" class="citation book cs1">World Health Organization (2019). <i>Executive summary: the selection and use of essential medicines 2019: report of the 22nd WHO Expert Committee on the selection and use of essential medicines</i>. Geneva: World Health Organization. hdl:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://hdl.handle.net/10665%2F325773  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://hdl.handle.net/10665%2F325773'" tppabs="https://hdl.handle.net/10665%2F325773" class="external text external">10665/325773</a></span>. WHO/MVP/EMP/IAU/2019.05. License: CC BY-NC-SA 3.0 IGO.</cite></span></li><li id="cite_note-5"> <span id="mw-reference-text-cite_note-5" class="mw-reference-text"><cite class="citation book cs1">World Health Organization (2019). <i>The selection and use of essential medicines: report of the WHO Expert Committee on Selection and Use of Essential Medicines, 2019 (including the 21st WHO Model List of Essential Medicines and the 7th WHO Model List of Essential Medicines for Children)</i>. Geneva: World Health Organization. hdl:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://hdl.handle.net/10665%2F330668  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://hdl.handle.net/10665%2F330668'" tppabs="https://hdl.handle.net/10665%2F330668" class="external text external">10665/330668</a></span>. ISBN<span>&nbsp;</span><bdi>9789241210300</bdi>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0512-3054  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0512-3054'" tppabs="https://www.worldcat.org/issn/0512-3054" class="external text external">0512-3054</a>. WHO technical report series;1021.</cite></span></li><li id="cite_note-Labeling-6"> <span id="mw-reference-text-cite_note-Labeling-6" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://labeling.pfizer.com/ShowLabeling.aspx?id=491  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://labeling.pfizer.com/ShowLabeling.aspx?id=491'" tppabs="http://labeling.pfizer.com/ShowLabeling.aspx?id=491" class="external text external">"TYGACIL U.S. Physician Prescribing Information"</a>. Pfizer<span class="reference-accessdate">. Retrieved <span class="nowrap">31 October</span> 2015</span>.</cite></span></li><li id="cite_note-7"> <span id="mw-reference-text-cite_note-7" class="mw-reference-text"><cite id="CITEREFScheinfeld2005" class="citation journal cs1">Scheinfeld N (2005). "Tigecycline: a review of a new glycylcycline antibiotic". <i>Journal of Dermatological Treatment</i>. <b>16</b> (4): 207–12. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F09546630510011810  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F09546630510011810'" tppabs="https://doi.org/10.1080%2F09546630510011810" class="external text external">10.1080/09546630510011810</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16249141  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16249141'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16249141" class="external text external">16249141</a>.</cite></span></li><li id="cite_note-Kaewpoowat-8"> <span id="mw-reference-text-cite_note-Kaewpoowat-8" class="mw-reference-text"><cite id="CITEREFKaewpoowatOstrosky-Zeichner2015" class="citation journal cs1">Kaewpoowat, Quanhathai; Ostrosky-Zeichner, Luis (1 February 2015). "Tigecycline: a critical safety review". <i>Expert Opinion on Drug Safety</i>. <b>14</b> (2): 335–342. doi:<a href="javascript:if(confirm('https://doi.org/10.1517%2F14740338.2015.997206  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1517%2F14740338.2015.997206'" tppabs="https://doi.org/10.1517%2F14740338.2015.997206" class="external text external">10.1517/14740338.2015.997206</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1474-0338  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1474-0338'" tppabs="https://www.worldcat.org/issn/1474-0338" class="external text external">1474-0338</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25539800  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25539800'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25539800" class="external text external">25539800</a>.</cite></span></li><li id="cite_note-Skrtić20112-9"> <span id="mw-reference-text-cite_note-Skrtić20112-9" class="mw-reference-text"><cite id="CITEREFSkrtićSriskanthadevanJhasGebbia2011" class="citation journal cs1">Skrtić, M; Sriskanthadevan, S; Jhas, B; Gebbia, M; Wang, X; Wang, Z; Hurren, R; Jitkova, Y; Gronda, M; Maclean, N; Lai, CK; Eberhard, Y; Bartoszko, J; Spagnuolo, P; Rutledge, AC; Datti, A; Ketela, T; Moffat, J; Robinson, BH; Cameron, JH; Wrana, J; Eaves, CJ; Minden, MD; Wang, JC; Dick, JE; Humphries, K; Nislow, C; Giaever, G; Schimmer, AD (2011). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3221282  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3221282'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3221282" class="external text external">"Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia"</a>. <i>Cancer Cell</i>. <b>20</b> (5): 674–688. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.ccr.2011.10.015  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.ccr.2011.10.015'" tppabs="https://doi.org/10.1016%2Fj.ccr.2011.10.015" class="external text external">10.1016/j.ccr.2011.10.015</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3221282  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3221282'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3221282" class="external text external">3221282</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22094260  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22094260'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22094260" class="external text external">22094260</a>.</cite></span></li><li id="cite_note-10"> <span id="mw-reference-text-cite_note-10" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.toku-e.com/Assets/MIC/Tigecycline.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.toku-e.com/Assets/MIC/Tigecycline.pdf'" tppabs="http://www.toku-e.com/Assets/MIC/Tigecycline.pdf" class="external text external">"Tigecycline<span>&nbsp;</span>: Susceptibility and Minimum Inhibitory Concentration (MIC) Data"</a> <span class="cs1-format">(PDF)</span>. <i>Toku-e.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">13 March</span> 2017</span>.</cite></span></li><li id="cite_note-11"> <span id="mw-reference-text-cite_note-11" class="mw-reference-text">Tygacil [package insert]. Philadelphia, PA: Wyeth Pharmaceuticals; 2005. Updated July 2010.</span></li><li id="cite_note-12"> <span id="mw-reference-text-cite_note-12" class="mw-reference-text"><cite id="CITEREFPournarasKoumakiSpanakisGennimata2016" class="citation journal cs1">Pournaras, Spyros; Koumaki, Vasiliki; Spanakis, Nicholas; Gennimata, Vasiliki; Tsakris, Athanassios (2016). "Current perspectives on tigecycline resistance in Enterobacteriaceae: susceptibility testing issues and mechanisms of resistance". <i>International Journal of Antimicrobial Agents</i>. <b>48</b> (1): 11–18. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.ijantimicag.2016.04.017  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.ijantimicag.2016.04.017'" tppabs="https://doi.org/10.1016%2Fj.ijantimicag.2016.04.017" class="external text external">10.1016/j.ijantimicag.2016.04.017</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27256586  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27256586'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27256586" class="external text external">27256586</a>.</cite></span></li><li id="cite_note-13"> <span id="mw-reference-text-cite_note-13" class="mw-reference-text"><cite id="CITEREFMuralidharan2005" class="citation journal cs1">Muralidharan, Gopal (January 2005). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC538906  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC538906'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC538906" class="external text external">"Pharmacokinetics of tigecycline after single and multiple doses in healthy subjects"</a>. <i>Antimicrobial Agents and Chemotherapy</i>. <b>49</b> (1): 220–229. doi:<a href="javascript:if(confirm('https://doi.org/10.1128%2Faac.49.1.220-229.2005  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1128%2Faac.49.1.220-229.2005'" tppabs="https://doi.org/10.1128%2Faac.49.1.220-229.2005" class="external text external">10.1128/aac.49.1.220-229.2005</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC538906  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC538906'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC538906" class="external text external">538906</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15616299  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15616299'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15616299" class="external text external">15616299</a>.</cite></span></li><li id="cite_note-FDA-14"> <span id="mw-reference-text-cite_note-FDA-14" class="mw-reference-text"><cite id="CITEREFWyeth_Pharmaceuticals_Inc." class="citation web cs1">Wyeth Pharmaceuticals Inc. <a href="javascript:if(confirm('http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021821s021lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021821s021lbl.pdf'" tppabs="http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021821s021lbl.pdf" class="external text external">"Food and Drug Administration, TYGACIL® (tigecycline) FOR INJECTION for intravenous use Prescribing Information"</a> <span class="cs1-format">(PDF)</span>. <i>FDA U.S. Food and Drug Administration</i>. U.S. Department of Health &amp; Human Services. p.<span>&nbsp;</span>16.</cite></span></li><li id="cite_note-pmid26282838-15"> <span id="mw-reference-text-cite_note-pmid26282838-15" class="mw-reference-text"><cite id="CITEREFHemphillJones2015" class="citation journal cs1">Hemphill MT, Jones KR (2015). <a href="javascript:if(confirm('https://doi.org/10.1016/j.jcf.2015.07.008  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016/j.jcf.2015.07.008'" tppabs="https://doi.org/10.1016/j.jcf.2015.07.008" class="external text external">"Tigecycline-induced acute pancreatitis in a cystic fibrosis patient: A case report and literature review"</a>. <i>J Cyst Fibros</i>. <b>15</b> (1): e9–11. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.jcf.2015.07.008  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.jcf.2015.07.008'" tppabs="https://doi.org/10.1016%2Fj.jcf.2015.07.008" class="external text external">10.1016/j.jcf.2015.07.008</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26282838  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26282838'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26282838" class="external text external">26282838</a>.</cite></span></li><li id="cite_note-16"> <span id="mw-reference-text-cite_note-16" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.fda.gov/Drugs/DrugSafety/ucm224370.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/Drugs/DrugSafety/ucm224370.htm'" tppabs="https://www.fda.gov/Drugs/DrugSafety/ucm224370.htm" class="external text external">"FDA Drug Safety Communication: Increased risk of death with Tygacil (tigecycline) compared to other antibiotics used to treat similar infections"</a>. <i>Fda.gov</i>. 27 September 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">13 March</span> 2017</span>.</cite></span></li><li id="cite_note-Dixit-17"> <span id="mw-reference-text-cite_note-Dixit-17" class="mw-reference-text"><cite id="CITEREFDixit2014" class="citation journal cs1">Dixit, Deepali (6 March 2014). "The role of tigecycline in the treatment of infections in light of the new black box warning". <i>Expert Review of Anti-infective Therapy</i>. <b>12</b> (4): 397–400. doi:<a href="javascript:if(confirm('https://doi.org/10.1586%2F14787210.2014.894882  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1586%2F14787210.2014.894882'" tppabs="https://doi.org/10.1586%2F14787210.2014.894882" class="external text external">10.1586/14787210.2014.894882</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24597542  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24597542'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24597542" class="external text external">24597542</a>.</cite></span></li><li id="cite_note-18"> <span id="mw-reference-text-cite_note-18" class="mw-reference-text"><cite id="CITEREFZimmermanRaibleHarperMatschke2008" class="citation journal cs1">Zimmerman, James J.; Raible, Donald G.; Harper, Dawn M.; Matschke, Kyle; Speth, John L. (1 July 2008). "Evaluation of a Potential Tigecycline-Warfarin Drug Interaction". <i>Pharmacotherapy</i>. <b>28</b> (7): 895–905. doi:<a href="javascript:if(confirm('https://doi.org/10.1592%2Fphco.28.7.895  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1592%2Fphco.28.7.895'" tppabs="https://doi.org/10.1592%2Fphco.28.7.895" class="external text external">10.1592/phco.28.7.895</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1875-9114  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1875-9114'" tppabs="https://www.worldcat.org/issn/1875-9114" class="external text external">1875-9114</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18576904  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18576904'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18576904" class="external text external">18576904</a>.</cite></span></li><li id="cite_note-19"> <span id="mw-reference-text-cite_note-19" class="mw-reference-text"><a href="javascript:if(confirm('http://www.medscape.com/viewarticle/557981_2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.medscape.com/viewarticle/557981_2'" tppabs="http://www.medscape.com/viewarticle/557981_2" class="external text external">Tigecycline: A Novel Broad-Spectrum Antimicrobial: Pharmacology and Mechanism of Action</a> Christine M. Slover, PharmD, Infectious Diseases Fellow, Keith A. Rodvold, PharmD and Larry H. Danziger, PharmD, Professor, Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, IL</span></li><li id="cite_note-Nguyen-20"> <span id="mw-reference-text-cite_note-Nguyen-20" class="mw-reference-text"><cite id="CITEREFNguyen2014" class="citation journal cs1">Nguyen, Fabian (May 2014). "Tetracycline antibiotics and resistance mechanisms". <i>Biol Chem</i>. <b>395</b> (5): 559–75. doi:<a href="javascript:if(confirm('https://doi.org/10.1515%2Fhsz-2013-0292  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1515%2Fhsz-2013-0292'" tppabs="https://doi.org/10.1515%2Fhsz-2013-0292" class="external text external">10.1515/hsz-2013-0292</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24497223  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24497223'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24497223" class="external text external">24497223</a>.</cite></span></li><li id="cite_note-Hoffman-21"> <span id="mw-reference-text-cite_note-Hoffman-21" class="mw-reference-text"><cite id="CITEREFHoffman2007" class="citation journal cs1">Hoffman, Matthew (25 May 2007). "Metabolism, Excretion, and Pharmacokinetics of [14C]Tigecycline, a First-In-Class Glycylcycline Antibiotic, after Intravenous Infusion to Healthy Male Subjects". <i>Drug Metabolism and Disposition</i>. <b>35</b> (9): 1543–1553. doi:<a href="javascript:if(confirm('https://doi.org/10.1124%2Fdmd.107.015735  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1124%2Fdmd.107.015735'" tppabs="https://doi.org/10.1124%2Fdmd.107.015735" class="external text external">10.1124/dmd.107.015735</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17537869  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17537869'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17537869" class="external text external">17537869</a>.</cite></span></li><li id="cite_note-22"> <span id="mw-reference-text-cite_note-22" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.medicines.org.uk/emc/medicine/17779  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.medicines.org.uk/emc/medicine/17779'" tppabs="https://www.medicines.org.uk/emc/medicine/17779" class="external text external">"Tygacil 50mg powder for solution for infusion - Summary of Product Characteristics (SPC) - (eMC)"</a>. <i>Medicines.org.uk</i><span class="reference-accessdate">. Retrieved <span class="nowrap">13 March</span> 2017</span>.</cite></span></li><li id="cite_note-23"> <span id="mw-reference-text-cite_note-23" class="mw-reference-text"><cite id="CITEREFBetriuRodríguez-AvialSánchezGómez2002" class="citation journal cs1">Betriu C, Rodríguez-Avial I, Sánchez BA, Gómez M, Picazo JJ (2002). <a href="javascript:if(confirm('https://doi.org/10.1093/jac/dkf196  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093/jac/dkf196'" tppabs="https://doi.org/10.1093/jac/dkf196" class="external text external">"Comparative in vitro activities of tigecycline (GAR-936) and other antimicrobial agents against <i>Stenotrophomonas maltophilia</i>"</a>. <i>J Antimicrob Chemother</i>. <b>50</b> (5): 758–59. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1093%2Fjac%2Fdkf196  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fjac%2Fdkf196'" tppabs="https://doi.org/10.1093%2Fjac%2Fdkf196" class="external text external">10.1093/jac/dkf196</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12407139  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12407139'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12407139" class="external text external">12407139</a>.</cite></span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><cite class="citation web cs1"><a href="javascript:if(confirm('https://druginfo.nlm.nih.gov/drugportal/name/tigecycline  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://druginfo.nlm.nih.gov/drugportal/name/tigecycline'" tppabs="https://druginfo.nlm.nih.gov/drugportal/name/tigecycline" class="external text external">"Tigecycline"</a>. <i>Drug Information Portal</i>. U.S. National Library of Medicine.</cite></li></ul>

<div role="navigation" class="navbox" aria-labelledby="Antibacterials_that_inhibit_protein_synthesis_(J01A,_J01B,_J01F,_J01G,_QJ01XQ)" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Antibacterials_that_inhibit_protein_synthesis_(J01A,_J01B,_J01F,_J01G,_QJ01XQ)" style="font-size:114%;margin:0 4em">Antibacterials that inhibit protein synthesis (J01A, J01B, J01F, J01G, QJ01XQ)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">30S</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Aminoglycosides<br>(initiation inhibitors)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">-mycin (<i>Streptomyces</i>)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Streptomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Streptomycin" title="Streptomycin">Streptomycin</a><sup>#</sup></li>
<li>Dihydrostreptomycin</li></ul>

<ul><li><a href="Neomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Neomycin" title="Neomycin">Neomycin</a><sup>#</sup>
<ul><li><a href="Framycetin.htm" tppabs="https://ptable.com/wiki/compounds/A/Framycetin" title="Framycetin" class="mw-redirect">Framycetin</a></li>
<li>Paromomycin</li>
<li><a href="Ribostamycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Ribostamycin" title="Ribostamycin">Ribostamycin</a></li></ul></li></ul>

<ul><li><a href="Kanamycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Kanamycin" title="Kanamycin" class="mw-redirect">Kanamycin</a>
<ul><li><a href="Amikacin.htm" tppabs="https://ptable.com/wiki/compounds/A/Amikacin" title="Amikacin">Amikacin</a><sup>#</sup></li>
<li>Arbekacin</li>
<li><a href="Bekanamycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Bekanamycin" title="Bekanamycin">Bekanamycin</a></li>
<li>Dibekacin</li>
<li><a href="Tobramycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Tobramycin" title="Tobramycin">Tobramycin</a></li></ul></li></ul>

<ul><li><a href="Spectinomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Spectinomycin" title="Spectinomycin">Spectinomycin</a><sup>#</sup></li>
<li><a href="Hygromycin_B.htm" tppabs="https://ptable.com/wiki/compounds/A/Hygromycin_B" title="Hygromycin B">Hygromycin B</a></li>
<li><a href="Apramycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Apramycin" title="Apramycin">Apramycin</a></li>
<li><a href="Puromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Puromycin" title="Puromycin">Puromycin</a></li>
<li>Nourseothricin</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">-micin (<i>Micromonospora</i>)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Gentamicin.htm" tppabs="https://ptable.com/wiki/compounds/A/Gentamicin" title="Gentamicin">Gentamicin</a><sup>#</sup>
<ul><li><a href="Netilmicin.htm" tppabs="https://ptable.com/wiki/compounds/A/Netilmicin" title="Netilmicin">Netilmicin</a></li>
<li>Sisomicin</li>
<li>Plazomicin<sup>†</sup></li>
<li>Isepamicin</li></ul></li></ul>

<ul><li>Verdamicin</li></ul>

<ul><li>Astromicin</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Tetracycline antibiotics<br>(tRNA binding)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Tetracyclines</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Doxycycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Doxycycline" title="Doxycycline">Doxycycline</a><sup>#</sup></li>
<li>Chlortetracycline</li>
<li><a href="Clomocycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Clomocycline" title="Clomocycline">Clomocycline</a></li>
<li><a href="Demeclocycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Demeclocycline" title="Demeclocycline">Demeclocycline</a></li>
<li>Eravacycline</li>
<li><a href="Lymecycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Lymecycline" title="Lymecycline">Lymecycline</a></li>
<li>Meclocycline<sup>‡</sup></li>
<li><a href="Metacycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Metacycline" title="Metacycline">Metacycline</a></li>
<li><a href="Minocycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Minocycline" title="Minocycline">Minocycline</a></li>
<li>Omadacycline</li>
<li><a href="Oxytetracycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxytetracycline" title="Oxytetracycline">Oxytetracycline</a></li>
<li>Penimepicycline</li>
<li><a href="Rolitetracycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Rolitetracycline" title="Rolitetracycline">Rolitetracycline</a></li>
<li>Sarecycline</li>
<li><a href="Tetracycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetracycline" title="Tetracycline">Tetracycline</a><sup>#</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Glycylcyclines</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Tigecycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Tigecycline" title="Tigecycline">Tigecycline</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">50S</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="2-Oxazolidone.htm" tppabs="https://ptable.com/wiki/compounds/A/2-Oxazolidone" title="2-Oxazolidone">Oxazolidinone</a><br>(initiation inhibitors)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Eperezolid</li>
<li><a href="Linezolid.htm" tppabs="https://ptable.com/wiki/compounds/A/Linezolid" title="Linezolid">Linezolid</a><sup>#</sup></li>
<li>Posizolid</li>
<li>Radezolid</li>
<li>Ranbezolid</li>
<li>Sutezolid</li>
<li>Tedizolid</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Peptidyl transferase</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Amphenicol.htm" tppabs="https://ptable.com/wiki/compounds/A/Amphenicol" title="Amphenicol">Amphenicols</a></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Chloramphenicol.htm" tppabs="https://ptable.com/wiki/compounds/A/Chloramphenicol" title="Chloramphenicol">Chloramphenicol</a><sup>#</sup></li>
<li>Azidamfenicol</li>
<li><a href="Thiamphenicol.htm" tppabs="https://ptable.com/wiki/compounds/A/Thiamphenicol" title="Thiamphenicol">Thiamphenicol</a></li>
<li><a href="Florfenicol.htm" tppabs="https://ptable.com/wiki/compounds/A/Florfenicol" title="Florfenicol">Florfenicol</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Pleuromutilins</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Lefamulin</li>
<li><a href="Retapamulin.htm" tppabs="https://ptable.com/wiki/compounds/A/Retapamulin" title="Retapamulin">Retapamulin</a></li>
<li>Tiamulin</li>
<li>Valnemulin</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">MLS (transpeptidation/translocation)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Macrolides</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Azithromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Azithromycin" title="Azithromycin">Azithromycin</a><sup>#</sup></li>
<li>Boromycin</li>
<li><a href="Clarithromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Clarithromycin" title="Clarithromycin">Clarithromycin</a><sup>#</sup></li>
<li><a href="Dirithromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Dirithromycin" title="Dirithromycin">Dirithromycin</a></li>
<li><a href="Erythromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Erythromycin" title="Erythromycin">Erythromycin</a><sup>#</sup></li>
<li>Flurithromycin</li>
<li><a href="Josamycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Josamycin" title="Josamycin">Josamycin</a></li>
<li>Midecamycin</li>
<li>Miocamycin</li>
<li><a href="Oleandomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Oleandomycin" title="Oleandomycin">Oleandomycin</a></li>
<li>Rokitamycin</li>
<li><a href="Roxithromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Roxithromycin" title="Roxithromycin">Roxithromycin</a></li>
<li>Spiramycin</li>
<li><a href="Troleandomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Troleandomycin" title="Troleandomycin">Troleandomycin</a></li>
<li><a href="Tylosin.htm" tppabs="https://ptable.com/wiki/compounds/A/Tylosin" title="Tylosin">Tylosin</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Ketolides</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Telithromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Telithromycin" title="Telithromycin">Telithromycin</a><sup>‡</sup></li>
<li>Cethromycin</li>
<li>Solithromycin<sup>†</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Lincosamides</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Clindamycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Clindamycin" title="Clindamycin">Clindamycin</a><sup>#</sup></li>
<li><a href="Lincomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Lincomycin" title="Lincomycin">Lincomycin</a></li>
<li>Pirlimycin</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Streptogramins</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Pristinamycin</li>
<li>Quinupristin/dalfopristin</li>
<li>Virginiamycin</li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">EF-G</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="Steroid_antibacterials" scope="row" class="navbox-group" style="width:1%">Steroid antibacterials</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Fusidic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Fusidic_acid" title="Fusidic acid">Fusidic acid</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;"><div><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div></div></td></tr></tbody></table></div>





<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-08-06" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Tigecycline&oldid=971429466  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Tigecycline&oldid=971429466'" tppabs="https://en.wikipedia.org/wiki/?title=Tigecycline&oldid=971429466">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>